» Authors » Izumi Iida

Izumi Iida

Explore the profile of Izumi Iida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 109
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Yamada H, Yamaguchi J, Iida I, Okuyama S
Nihon Yakurigaku Zasshi . 2006 Aug; 127(6):473-80. PMID: 16880698
No abstract available.
12.
Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Nagase Y, et al.
Bioorg Med Chem . 2006 Jan; 14(10):3307-19. PMID: 16434202
The optimization of the distance between two key pharmacophore features within our first hit compounds 1a and 2a led to the identification of a new class of potent non-peptidic antagonists...
13.
Suzuki A, Iida I, Hirota M, Akimoto M, Higuchi S, Suwa T, et al.
Drug Metab Pharmacokinet . 2004 Dec; 18(2):104-13. PMID: 15618724
To clarify whether CYP2C19 is involved in the overall metabolism of clarithromycin (CAM) or not, in vitro studies using human liver microsomes and recombinant CYPs were performed by an approach...
14.
Akimoto M, Iida I, Itoga H, Miyata A, Kawahara S, Kohno Y
Eur J Drug Metab Pharmacokinet . 2004 Nov; 29(3):179-86. PMID: 15537169
The human cytochrome P450 (CYP) isoforms catalyzing the oxidation metabolism of desglymidodrine (DMAE), an active metabolite of midodrine, were studied. Recombinant human CYP2D6, 1A2 and 2C19 exhibited appreciable catalytic activity...
15.
Iida I, Miyata A, Arai M, Hirota M, Akimoto M, Higuchi S, et al.
Drug Metab Dispos . 2004 Jan; 32(1):7-9. PMID: 14709614
The effects of allelic variants of CYP2C9 (CYP2C9*2 and CYP2C9*3) on lornoxicam 5'-hydroxylation were studied using the corresponding variant protein expressed in baculovirus-infected insect cells and human liver microsomes of...